An exciting development in cancer research has been the discovery that the tumor microenvironment (TME) exhibits unique characteristics from healthy tissue. Researchers have hypothesized these unique tumor characteristics could be used as a targeting mechanism, further improving the precision of treatment delivery.

By seeking out highly expressed markers found in many tumors but not found in healthy tissue, canSEEK™ is a promising technology for use in next generation radiopharmaceuticals, as it may allow for the precision treatment of a variety of solid tumor cancers.